Evidence map›Paper›PMID 40883754›Full record

ArticleBMC pediatrics2025

Association of early hyperglycemia with morbidity and mortality in very low birth weight infants.

Jingwen Zhu, Xiyu He, Ming Guo

Abstract read
In one paragraph

Article in BMC pediatrics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jingwen ZhuDepartment of Pediatric, Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Xiyu HeDepartment of Pediatric, Fifth Medical Center of PLA General Hospital, Beijing, 100039, China.
Ming GuoDepartment of Pediatric, Fifth Medical Center of PLA General Hospital, Beijing, 100039, China. zjw198474@163.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the association between hyperglycemia and morbidity/mortality in very-low-birth-weight infants.

methodsThis retrospective study analyzed 255 very-low-birth-weight infants admitted to a Neonatal Intensive Care Unit (2020-2024). Infants were stratified by glucose levels: hyperglycemia (> 150 mg/dL) vs. normoglycemia (>47 mg/dl, ≤ 150 mg/dL). Hyperglycemic infants were further categorized by duration (≤ 72 vs. >72 h) and severity (150-220 vs. ≥ 220 mg/dL). Outcomes included retinopathy of prematurity (ROP), intraventricular hemorrhage (IVH), and mortality. Logistic regression was used to assess independent associations.

resultsHyperglycemia occurred in 44.7% (114 of 255) of infants. Compared to normoglycemic infants, hyperglycemic infants had higher incidences of ROP (p < 0.001), IVH (p < 0.001), and mortality ( p = 0.046). Logistic regression confirmed hyperglycemia as an significantly associated factor of ROP and IVH (p < 0.05) but not mortality (p = 0.777). Prolonged hyperglycemia (> 72 h) increased ROP risk (p < 0.05), while severe hyperglycemia (≥ 220 mg/dL) elevated IVH risk ( p < 0.05).

conclusionsHyperglycemia in very-low-birth-weight infants is associated with higher incidences of ROP and IVH, with both duration and severity influencing the risk. Strict glucose monitoring and timely intervention are crucial to reduce these complications.

Indexed as

Cerebral Intraventricular HemorrhageHyperglycemiaInfant, Premature, DiseasesInfant, Very Low Birth WeightRetinopathy of PrematurityBlood GlucoseFemaleHumansInfant, NewbornIntensive Care Units, NeonatalLogistic ModelsMaleRetrospective StudiesRisk FactorsBlood GlucoseHyperglycemiaIntraventricular hemorrhageMortalityRetinopathy of prematurityVery low birth weight infants

Identifiers

PMID40883754
PMCPMC12395794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.